106 related articles for article (PubMed ID: 19809888)
1. Coronary heart disease risk screening: the community pharmacy Healthy Heart Assessment Service.
Donyai P; Van den Berg M
Pharm World Sci; 2009 Dec; 31(6):643-7. PubMed ID: 19809888
[TBL] [Abstract][Full Text] [Related]
2. Community pharmacist assessment of 10-year risk of coronary heart disease for union workers and their dependents.
Liu Y; Mentele LJ; McDonough RP; Carruthers KM; Doucette WR
J Am Pharm Assoc (2003); 2008; 48(4):515-7. PubMed ID: 18653428
[TBL] [Abstract][Full Text] [Related]
3. Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease.
Blenkinsopp A; Anderson C; Armstrong M
J Public Health Med; 2003 Jun; 25(2):144-53. PubMed ID: 12848404
[TBL] [Abstract][Full Text] [Related]
4. The Inverse Care Law might not apply to preventative health services in community pharmacy.
Zonneveld S; Versace VL; Krass I; Clark RA; Shih S; Detert Oude Weme S; Mc Namara KP
Res Social Adm Pharm; 2021 May; 17(5):875-884. PubMed ID: 33092979
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a cardiovascular disease opportunistic risk assessment pilot ('Heart MOT' service) in community pharmacies.
Horgan JM; Blenkinsopp A; McManus RJ
J Public Health (Oxf); 2010 Mar; 32(1):110-6. PubMed ID: 19864496
[TBL] [Abstract][Full Text] [Related]
6. Regional osteoporosis screening, referral, and monitoring program in community pharmacies: findings from Project ImPACT: Osteoporosis.
Goode JV; Swiger K; Bluml BM
J Am Pharm Assoc (2003); 2004; 44(2):152-60. PubMed ID: 15098849
[TBL] [Abstract][Full Text] [Related]
7. The corporatization of community pharmacy: implications for service provision, the public health function, and pharmacy's claims to professional status in the United Kingdom.
Bush J; Langley CA; Wilson KA
Res Social Adm Pharm; 2009 Dec; 5(4):305-18. PubMed ID: 19962674
[TBL] [Abstract][Full Text] [Related]
8. Involving the public and other stakeholders in development and evaluation of a community pharmacy alcohol screening and brief advice service.
Krska J; Mackridge AJ
Public Health; 2014 Apr; 128(4):309-16. PubMed ID: 24713598
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular disease risk screening by pharmacists: a behavior change wheel guided qualitative analysis.
Almansour HA; Mekonnen AB; Aloudah NM; Alhawassi TM; Mc Namara K; Chaar B; Krass I; Saini B
Res Social Adm Pharm; 2020 Feb; 16(2):149-159. PubMed ID: 31027964
[TBL] [Abstract][Full Text] [Related]
10. Bone health screening, education, and referral project in northwest Iowa: creating a model for community pharmacies.
Johnson JF; Koenigsfeld C; Hughell L; Parsa RA; Bravard S
J Am Pharm Assoc (2003); 2008; 48(3):379-87. PubMed ID: 18595823
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with the intensity of government remunerated and unremunerated service provision in community pharmacies.
Czarniak P; Krass I; Sunderland B; Sim TF; Carter S
Res Social Adm Pharm; 2021 Sep; 17(9):1614-1622. PubMed ID: 33423903
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of a multidisciplinary partnership to improve cardiac wellness: an opportunity for pharmacists.
Miller SW; Darsey E; Heard TJ; Williams J; Kelly M; Norman A; Ter Riet LB
Consult Pharm; 2010 Feb; 25(2):105-16. PubMed ID: 20211823
[TBL] [Abstract][Full Text] [Related]
13. Establishing a cardiovascular health and wellness program in a community pharmacy: screening for metabolic syndrome.
Olenak JL; Calpin M
J Am Pharm Assoc (2003); 2010; 50(1):32-6. PubMed ID: 20097637
[TBL] [Abstract][Full Text] [Related]
14. Sexual and reproductive health services provided by community pharmacists: a scoping review.
Navarrete J; Yuksel N; Schindel TJ; Hughes CA
BMJ Open; 2021 Jul; 11(7):e047034. PubMed ID: 34312200
[TBL] [Abstract][Full Text] [Related]
15. Men's health initiative risk assessment study: effect of community pharmacy-based screening.
Boyle TC; Coffey J; Palmer T
J Am Pharm Assoc (2003); 2004; 44(5):569-77. PubMed ID: 15496042
[TBL] [Abstract][Full Text] [Related]
16. A national survey exploring oral healthcare service provision across Australian community pharmacies.
Freeman CR; Abdullah N; Ford PJ; Taing MW
BMJ Open; 2017 Sep; 7(9):e017940. PubMed ID: 28963314
[TBL] [Abstract][Full Text] [Related]
17. A feasibility study of community pharmacists performing depression screening services.
O'Reilly CL; Wong E; Chen TF
Res Social Adm Pharm; 2015; 11(3):364-81. PubMed ID: 25438728
[TBL] [Abstract][Full Text] [Related]
18. Pharmacists' experience of a diabetes risk-assessment service and analytical quality control in community pharmacies - A focus-group study.
Risøy AJ; Skeide Kjome RL; Svensberg K; Råheim M; Sølvik UØ
Res Social Adm Pharm; 2021 Jul; 17(7):1259-1266. PubMed ID: 34155978
[TBL] [Abstract][Full Text] [Related]
19. Predictors of health promotion behavior in women without prior history of coronary heart disease.
Thanavaro JL; Moore SM; Anthony M; Narsavage G; Delicath T
Appl Nurs Res; 2006 Aug; 19(3):149-55. PubMed ID: 16877194
[TBL] [Abstract][Full Text] [Related]
20. Summative service and stakeholder evaluation of an NHS-funded community Pharmacy Emergency Repeat Medication Supply Service (PERMSS).
Nazar H; Nazar Z; Simpson J; Yeung A; Whittlesea C
BMJ Open; 2016 Jan; 6(1):e009736. PubMed ID: 26787252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
